Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹390 Cr
Revenue (TTM)
₹4,095 Cr
Net Profit (TTM)
₹1,062 Cr
ROE
18.3 %
ROCE
21.5 %
P/E Ratio
1.7
P/B Ratio
--
Industry P/E
34.72
EV/EBITDA
0.2
Div. Yield
0 %
Debt to Equity
0
Book Value
₹28514.7
EPS
₹4894.5
Face value
10
Shares outstanding
8,245,893
CFO
8,351.80 Cr
EBITDA
9,318.30 Cr
Net Profit
4,116.60 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
--
Incorporated
1989
Chairman
Sharvil P Patel
Managing Director
Swati Rohan Dalal
Group
Cadila
Headquarters
Ahmedabad, Gujarat
Website
--
Annual Reports
The P/E ratio of Zydus Healthcare Ltd is 1.72 times as on 03-Sep-2003, a 95 discount to its peers’ median range of 34.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Zydus Healthcare Ltd are Rs -- and Rs -- as of 20-Mar-2026.
Zydus Healthcare Ltd has a market capitalisation of ₹ 390 Cr as on 03-Sep-2003. As per SEBI classification, it is a company.
Before investing in Zydus Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.